Sehwan Chun

Efficacy and safety of Lenzumestrocel (Neuronata-R® inj.) in patients with amyotrophic lateral sclerosis (ALSUMMIT study): study protocol for a multicentre, randomized, double-blind, parallel-group, sham procedure-controlled, phase III trial

J. Sung, B. Kim, K. Kim, 2022, Trials.

Update on the Genetics of Systemic Lupus Erythematosus: Genome-Wide Association Studies and Beyond

Kwangwoo Kim, Young-Chang Kwon, A. Mak, 2019, Cells.

Safety and tolerability of bone marrow–derived mesenchymal stem cells in lupus animal models and a phase I clinical trial in humans

Jae-Yong Nam, Chan-Bum Choi, Young-Tae Lee, 2022, Lupus.

Allele‐Specific Quantification of HLA–DRB1 Transcripts Reveals Imbalanced Allelic Expression That Modifies the Amino Acid Effects in HLA–DRβ1

J. Cui, S. Bang, Hye-Soon Lee, 2020, Arthritis & rheumatology.

Long-term survival benefits of intrathecal autologous bone marrow-derived mesenchymal stem cells (Neuronata-R®: lenzumestrocel) treatment in ALS: Propensity-score-matched control, surveillance study

Jae-Yong Nam, Ju-Yong Oh, Sanggon Lee, 2023, Frontiers in Aging Neuroscience.

Efficacy and safety of Lenzumestrocel (Neuronata-R® inj.) in patients with amyotrophic lateral sclerosis (ALSUMMIT study): study protocol for a multicentre, randomized, double-blind, parallel-group, sham procedure-controlled, phase III trial

J. Sung, B. Kim, Byung-Jo Kim, 2022, Trials.

Deletion at 2q14.3 is associated with worse response to TNF-α blockers in patients with rheumatoid arthritis

S. Bang, Hye-Soon Lee, S. Bae, 2019, Arthritis Research & Therapy.

Human Arm Workout Classification by Arm Sleeve Device Based on Machine Learning Algorithms

Jooyong Kim, Sangun Kim, Sehwan Chun, 2023, Sensors.